by Jason Brandt (@jasondmg3)
Mad Men protagonist Don Draper works in the show’s fictional advertising agency, but the challenges he faces are real, and not much different than what many healthcare marketers face on a daily basis – meeting deadlines, incorporating new technologies, managing perceptions, and influencing behaviors all while ensuring personal growth.
The pharmaceutical industry and [...]
Tags:communication·Don Draper·healthcare·innovation·inspiration·Mad Men·marketing·Pharma·Pharmaceutical industry·social media·strategy·Trends
Last week Pixels & Pills’ editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan Kulkarni (@FDALawyers) of the Kulkarni Law Firm in Philadelphia. And while the questions answered in the conversation don’t constitute legal advice and [...]
Tags:#hcsm·@FDALawyers·Darshan Kulkarni·FDA·FDA Guidance·information·innovation·legal·Legal Issues·marketing·resources·social media·social media guidance·social media guidelines·Trends·Video
We’ve entered conference season and there are a lot of great ones on the horizon in the next few weeks. Our friend John Mack has a fairly comprehensive list over on his website, but he’s missing one that we’re particularly excited about.
The Life Sciences Innovation Forum, from Microsoft and our friends at ExL Pharma, promises to addresses [...]
Tags:conference·Conferences·Digital Tools·innovation·life sciences·life sciences innovation forum·Pharmaceutical industry·social media·strategy·technology·Trends
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
In The [...]
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Jason Brandt (@jasondmg3)
As Egon [...]
Tags:Best Practices·digital strategy·Digital Tools·Education·Opinion·social media·Social network·social networks·strategy·technology·Trends
by Briana Campbell (@MsMatchGirl)
By now, you’ve all had time to review the FDA’s draft guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices. And you’ve had time to read the multitude of responses that came after (if you didn’t, Fabio Gratton has compiled many of them for you). And, [...]
Tags:electronic media·emerging media·engagement·FDA·FDA Guidance·FDA guidelines·information·innovation·Pharma·Pharmaceutical industry·social media·Social network·strategy·Trends
by DJ Edgerton (@wiltonbound)
The question seems almost nonsensical at first – your Twitter followers may be really outstanding people, but they’re not organic chemists or researchers. And your Facebook fans, while devoted, probably do not, generally speaking, know how to move a new drug through the FDA approval process.
Just the same, it’s a mistake to [...]
Tags:Compliance·data·digital strategy·Digital Tools·Education·engagement·epatient·FDA·information·innovation·Legal Issues·marketing·Pharma·Pharmaceutical industry·R&D·research and development·social media·Social network·strategy·technology·Trends·user needs
by Briana Campbell (@MsMatchGirl)
We’ve spent a lot of this year (and last) talking about how pharma is running scared of social media. And we’ve spent some time telling them to just suck it up and do it anyway. And we’ve spent a bunch of time (two years, at least!) talking about how we’re waiting for [...]
Tags:Communities·epatient·patient bloggers·patient communities·Pharma·Pharmaceutical industry·Roche Diabetes·Roche Pharmaceutical·social media·social media strategy·social networks
by Briana Campbell (@MsMatchGirl)
People like to make out that the issues surrounding pharma’s involvement with social media are extraordinarily complex. I’m not so sure.
It’s over-simplistic – but still true – to say that the main worry with digital media for the pharmaceutical industry is the interactivity of social networks. You see, I don’t think it’s [...]
Tags:Compliance·DTC·Facebook·HIPPAA·marketing·off-label·Pharma·Pharma industry·Pharmaceutical industry·reporting·social media·Social network·Twitter
by Krissy Goelz (@krisgoelz)
We here at Pixels & Pills are well-known for our vocal support of digital technology and its place in healthcare – how it’s helped medicine and care to advance and to help people better than ever before. But today I wanted to look at one particular facet of healthcare, and how going [...]
Tags:Compliance·connections·e-patient·e-patients·epatient·Health care·Medicine·personalization·social media·social networks·technology
